Breast Cancer and Reconstruction: Understanding the Oncologic Pathway
Reconstruction is one part of a wider cancer journey — here is how oncologic care shapes its options and timing.
Read article →
Stop Tailoring, Start Positioning
Over the past month, we have explored the clinical, biological, and economic evolution of prepectoral breast reconstruction. We have moved beyond traditional…
Read article →
Advanced Biomedical Concept: 2026 Clinical Milestones
The first months of 2026 have marked a turning point for Advanced Biomedical Concept. Across clinical innovation, surgeon education, and global expansion,…
Read article →
Exashape™ in Prepectoral Breast Reconstruction: Key Findings Visualised
Medical literature is dense by necessity, but that doesn’t mean it has to be inaccessible. We created these animated visualisations to make…
Read article →
A Comparative Analysis of Long-Term Clinical Pathways
The evolution of prepectoral breast reconstruction has been driven by the search for techniques that provide both immediate aesthetic results and long-term…
Read article →
A New Partnership for Clinical Excellence
We are proud to announce that our flagship technology, Exashape, has officially entered the Swedish market through an exclusive distribution partnership with…
Read article →
Surgeon Spotlight | Restoring Femininity
It’s not often you meet a surgeon who speaks about 'magic' and 'vocation' in the same breath as 'biological matrices' and 'pre-pectoral…
Read article →
Patient-Reported Outcomes in Breast Reconstruction: Why BREAST-Q Matters
Why the patient’s own experience — measured with tools like the BREAST-Q — is increasingly the real test of reconstructive success.
Read article →
Complication Rates in Implant-Based Breast Reconstruction: What the Evidence Shows
The common complications, why reported rates vary so widely, and which levers are actually controllable.
Read article →
How to Read a Breast Reconstruction Clinical Study: Outcomes That Matter
How to judge a reconstruction study critically — design, endpoints, confounding, follow-up, and whether the evidence is product-specific.
Read article →